Overview

Vitamin D Market is poised to register a CAGR of 7% during the forecast period 2022 to 2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Vitamin D Market trends that shall affect the overall market growth. Furthermore, it includes detailed inIU Strengthation on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Vitamin D Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial inIU Strengthation pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Vitamin D Market:
• Koninkljike DSM N.V 
• Zhejiang Garden Biochemical High-Tech Co Ltd 
• Zhejiang Xinhecheng Co Ltd 
• Fermenta Biotech Ltd 
• Xiamen Jindawei Vitamin Co Ltd 
• BASF Se 
• Dishman Group 
• Taizhou Haisheng Pharmaceutical Co Lt
• Zhejiang Medicine Co Ltd 
• Glanbia PLC 
• PHW Group 
• Bio-Tech Pharmacal 
• Divi’s Nutraceutical 
• Synthesia
• Hangzhou Think Chemical Co Ltd 
• Sichuan Neijiang Huixin Pharmaceutical Co Ltd 
• Kingdom Nutrition Inc.
• McKinley Resources Inc. 
• New Gen Pharma Inc. 
• Taizhou Hisound Pharmaceutical Co Ltd
• Pharmavit 
• Tocris Bioscience
• Lycored
• Stabicoat Vitamins 
• Spectrum Chemical MFG Corp 
 (Note: The list of the major players will be updated with the latest market scenario and trends)

Vitamin D Market Segmentation:
By Analog
• Vitamin D3
• Vitamin D2

By IU Strength
• 500,000 IU
• 100,000 IU
• 40 MIU
• Others (1 MIU, 2 MIU, 4 MIU, 10 MIU, 15 MIU, 1,000 IU, and 2,000 IU)

By Form
• Dry
• Liquid

By Application
• Feed & pet food
• Animal feed
• Pet food
• Pharmaceuticals
• Functional food & beverages
• Personal care

By End User
• Adults
• Pregnant women
• Children

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Vitamin D Market By Analog, By IU Strength, By Form, By Application, By End User and By Region.
• To cater comprehensive inIU Strengthation on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1 Objectives of the Study 
   1.2 Market Definition 
   1.3 Market Scope 
       1.3.1 Years Considered for the Study
       1.3.2 Market Covered
   1.4 Currency 
   1.5 Limitations 
   1.6 Stakeholders 

 2. Research Methodology 
    2.1 Research Data 
        2.1.1 Secondary Data
              2.1.1.1 Key Data from Secondary Sources
        2.1.2 Primary Data
              2.1.2.1 Key Data from Primary Sources
    2.2 Market Size Estimation 
    2.3 Market Breakdown and Data Triangulation 
    2.4 Assumptions for the Study  

3. Executive Summary
   3.1 Market Outlook
   3.2 Segment Outlook
   3.3 Competitive Insights

4. Global Vitamin D Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Vitamin D Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Vitamin D Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Global Vitamin D Market, By Analog Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Vitamin D3
   7.2. Vitamin D2
 
8. Global Vitamin D Market, By IU Strength Historical Analysis and Forecast 2022-2028 (USD Million)
   8.1. 500,000 IU
   8.2. 100,000 IU
   8.3. 40 MIU
   8.4. Others (1 MIU, 2 MIU, 4 MIU, 10 MIU, 15 MIU, 1,000 IU, and 2,000 IU)

9. Global Vitamin D Market, By Form Historical Analysis and Forecast 2022-2028 (USD Million)
   9.1. Dry
   9.2. Liquid

10. Global Vitamin D Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
   10.1. Feed & pet food
   10.2. Animal feed
   10.3. Pet food
   10.4. Pharmaceuticals
   10.5. Functional food & beverages
   10.6. Personal care

11. Global Vitamin D Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
   11.1. Adults
   11.2. Pregnant women
   11.3. Children

12. North America Vitamin D Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   12.1. Introduction
   12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
        12.2.1. U.S.A
        12.2.2. Canada
        12.2.3. Mexico
   12.3. Market Size (USD Million) Forecast for North America 2022-2028

13. Latin America Vitamin D Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. Brazil
          13.2.2. Venezuela
          13.2.3. Argentina
          13.2.4. Rest of Latin America
    13.3. Market Size (USD Million) Forecast for Latin America 2022-2028

14. Europe Vitamin D Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. Germany
          14.2.2. U.K         
          14.2.3. France
          14.2.4. Italy
          14.2.5. Spain
          14.2.6. Russia
          14.2.7. Poland
          14.2.8. Rest of Europe
    14.3. Market Size (USD Million) Forecast for Europe 2022-2028

15. Asia Pacific Vitamin D Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    15.1. Introduction
    15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          15.2.1. Japan
          15.2.2. China
          15.2.3. India
          15.2.4. Australia and New Zealand
          15.2.5. ASEAN
          15.2.6. Rest of Asia Pacific
    15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

16. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    16.1. Introduction
    16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          16.2.1. GCC
          16.2.2. Israel
          16.2.3. South Africa
          16.2.4. Rest of MEA
    16.3. Market Size (USD Million) Forecast for MEA 2022-2028

17. Market Share Analysis and Competitive Landscape   
    17.1. Global Landscape - Key Players, Revenue and Presence
    17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    17.3. Global Emerging Companies
    17.4. North America - Market Share Analysis and Key Regional Players
    17.5. Europe - Market Share Analysis and Key Regional Players
    17.6. Asia Pacific - Market Share Analysis and Key Regional Players
    17.7. Global Key Player - Growth Matrix

18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    18.1. Koninkljike DSM N.V 
          18.1.1. Company Overview
          18.1.2. Product Portfolio
          18.1.3. SWOT Analysis
          18.1.4. Financial Overview
          18.1.5. Strategic Overview
    18.2. Zhejiang Garden Biochemical High-Tech Co Ltd
          18.2.1. Company Overview
          18.2.2. Product Portfolio
          18.2.3. SWOT Analysis
          18.2.4. Financial Overview
          18.2.5. Strategic Overview 
    18.3. Zhejiang Xinhecheng Co Ltd 
          18.3.1. Company Overview
          18.3.2. Product Portfolio
          18.3.3. SWOT Analysis
          18.3.4. Financial Overview
          18.3.5. Strategic Overview
    18.4. Fermenta Biotech Ltd 
          18.4.1. Company Overview
          18.4.2. Product Portfolio
          18.4.3. SWOT Analysis
          18.4.4. Financial Overview
          18.4.5. Strategic Overview
    18.5. Xiamen Jindawei Vitamin Co Ltd 
          18.5.1. Company Overview
          18.5.2. Product Portfolio
          18.5.3. SWOT Analysis
          18.5.4. Financial Overview
          18.5.5. Strategic Overview          
    18.6. BASF Se 
          18.6.1. Company Overview
          18.6.2. Product Portfolio
          18.6.3. SWOT Analysis
          18.6.4. Financial Overview
          18.6.5. Strategic Overview      
    18.7. Dishman Group 
          18.7.1. Company Overview
          18.7.2. Product Portfolio
          18.7.3. SWOT Analysis
          18.7.4. Financial Overview
          18.7.5. Strategic Overview
    18.8. Taizhou Haisheng Pharmaceutical Co Ltd 
          18.8.1. Company Overview
          18.8.2. Product Portfolio
          18.8.3. SWOT Analysis
          18.8.4. Financial Overview
          18.8.5. Strategic Overview 
    18.9. Zhejiang Medicine Co Ltd 
          18.9.1. Company Overview
          18.9.2. Product Portfolio
          18.9.3. SWOT Analysis
          18.9.4. Financial Overview
          18.9.5. Strategic Overview
    18.10.Glanbia PLC 
          18.10.1. Company Overview
          18.10.2. Product Portfolio
          18.10.3. SWOT Analysis
          18.10.4. Financial Overview
          18.10.5. Strategic Overview
    18.11. PHW Group 
          18.11.1. Company Overview
          18.11.2. Product Portfolio
          18.11.3. SWOT Analysis
          18.11.4. Financial Overview
          18.11.5. Strategic Overview
    18.12. Bio-Tech Pharmacal 
          18.12.1. Company Overview
          18.12.2. Product Portfolio
          18.12.3. SWOT Analysis
          18.12.4. Financial Overview
          18.12.5. Strategic Overview 
    18.13. Divi’s Nutraceutical 
          18.13.1. Company Overview
          18.13.2. Product Portfolio
          18.13.3. SWOT Analysis
          18.13.4. Financial Overview
          18.13.5. Strategic Overview
    18.14. Synthesia 
          18.14.1. Company Overview
          18.14.2. Product Portfolio
          18.14.3. SWOT Analysis
          18.14.4. Financial Overview
          18.14.5. Strategic Overview
    18.15. Hangzhou Think Chemical Co Ltd 
          18.15.1. Company Overview
          18.15.2. Product Portfolio
          18.15.3. SWOT Analysis
          18.15.4. Financial Overview
          18.15.5. Strategic Overview          
    18.16. Sichuan Neijiang Huixin Pharmaceutical Co Ltd
          18.16.1. Company Overview
          18.16.2. Product Portfolio
          18.16.3. SWOT Analysis
          18.16.4. Financial Overview
          18.16.5. Strategic Overview      
    18.17. Kingdom Nutrition Inc. 
          18.17.1. Company Overview
          18.17.2. Product Portfolio
          18.17.3. SWOT Analysis
          18.17.4. Financial Overview
          18.17.5. Strategic Overview
    18.18. McKinley Resources Inc. 
          18.18.1. Company Overview
          18.18.2. Product Portfolio
          18.18.3. SWOT Analysis
          18.18.4. Financial Overview
          18.18.5. Strategic Overview 
    18.19. New Gen Pharma Inc.
          18.19.1. Company Overview
          18.19.2. Product Portfolio
          18.19.3. SWOT Analysis
          18.19.4. Financial Overview
          18.19.5. Strategic Overview
    18.20. Taizhou Hisound Pharmaceutical Co Ltd 
          18.20.1. Company Overview
          18.20.2. Product Portfolio
          18.20.3. SWOT Analysis
          18.20.4. Financial Overview
          18.20.5. Strategic Overview
    18.21. Pharmavit 
          18.21.1. Company Overview
          18.21.2. Product Portfolio
          18.21.3. SWOT Analysis
          18.21.4. Financial Overview
          18.21.5. Strategic Overview
    18.22. Tocris Bioscience 
          18.22.1. Company Overview
          18.22.2. Product Portfolio
          18.22.3. SWOT Analysis
          18.22.4. Financial Overview
          18.22.5. Strategic Overview 
    18.23. Lycored 
          18.23.1. Company Overview
          18.23.2. Product Portfolio
          18.23.3. SWOT Analysis
          18.23.4. Financial Overview
          18.23.5. Strategic Overview
    18.24. Stabicoat Vitamins 
          18.24.1. Company Overview
          18.24.2. Product Portfolio
          18.24.3. SWOT Analysis
          18.24.4. Financial Overview
          18.24.5. Strategic Overview
    18.25. Spectrum Chemical MFG Corp 
          18.25.1. Company Overview
          18.25.2. Product Portfolio
          18.25.3. SWOT Analysis
          18.25.4. Financial Overview
          18.25.5. Strategic Overview          

19. Pre and Post COVID-19 Impact
    19.1. Positive influence on the healthcare industry
    19.2. The financial disruption of the manufacturing sector
    19.3. Impact of COVID-19 on emerging companies
    19.4. Significant mandates in the healthcare regulations initiated by administrations
    19.5. The overall economic slowdown of the developing and developed nations

20. FutureWise SME Key Takeaway Points for Client

Tables

Figures